Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 03, 2023

BUY
$0.78 - $1.42 $13,175 - $23,986
16,892 Added 34.3%
66,143 $77,000
Q4 2022

Feb 13, 2023

BUY
$0.79 - $1.23 $38,908 - $60,578
49,251 New
49,251 $38,000
Q3 2021

Nov 12, 2021

SELL
$1.74 - $2.6 $32,771 - $48,968
-18,834 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$1.51 - $4.23 $28,439 - $79,667
18,834 New
18,834 $66,000

Others Institutions Holding CTXR

About Citius Pharmaceuticals, Inc.


  • Ticker CTXR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 146,130,000
  • Market Cap $140M
  • Description
  • Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...
More about CTXR
Track This Portfolio

Track Jump Financial, LLC Portfolio

Follow Jump Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.